Global Cancer Supportive Care Market Research Report 2019
Table of Contents
Executive Summary
1 Cancer Supportive Care Market Overview
- 1.1 Product Overview and Scope of Cancer Supportive Care
- 1.2 Cancer Supportive Care Segment by Type
- 1.2.1 Global Cancer Supportive Care Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Nonsteroidal Erythropoietin Stimulating Agents
- 1.2.3 Opioid Analgesics
- 1.2.4 Anti-Imflammatory Drugs
- 1.2.5 Anti-Infective Drugs
- 1.2.6 Bisphosphonates
- 1.2.7 Anti-Emetics Drugs
- 1.2.8 Monoclonal Antibodies
- 1.2.9 Granulocyte Colony Stimulating Factor
- 1.3 Cancer Supportive Care Segment by Application
- 1.3.1 Cancer Supportive Care Consumption Comparison by Application (2014-2025)
- 1.3.2 Lung Cancer
- 1.3.3 Breast Cancer
- 1.3.4 Prostate Cancer
- 1.3.5 Liver Cancer
- 1.3.6 Bladder Cancer
- 1.3.7 Leukemia
- 1.3.8 Ovarian Cancer
- 1.3.9 Melanoma
- 1.3.10 Others
- 1.4 Global Cancer Supportive Care Market by Region
- 1.4.1 Global Cancer Supportive Care Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Cancer Supportive Care Market Size
- 1.5.1 Global Cancer Supportive Care Revenue (2014-2025)
- 1.5.2 Global Cancer Supportive Care Production (2014-2025)
2 Global Cancer Supportive Care Market Competition by Manufacturers
- 2.1 Global Cancer Supportive Care Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Cancer Supportive Care Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Cancer Supportive Care Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Cancer Supportive Care Production Sites, Area Served, Product Types
- 2.5 Cancer Supportive Care Market Competitive Situation and Trends
- 2.5.1 Cancer Supportive Care Market Concentration Rate
- 2.5.2 Cancer Supportive Care Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Cancer Supportive Care Production Market Share by Regions
- 3.1 Global Cancer Supportive Care Production Market Share by Regions
- 3.2 Global Cancer Supportive Care Revenue Market Share by Regions (2014-2019)
- 3.3 Global Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Cancer Supportive Care Production
- 3.4.1 North America Cancer Supportive Care Production Growth Rate (2014-2019)
- 3.4.2 North America Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Cancer Supportive Care Production
- 3.5.1 Europe Cancer Supportive Care Production Growth Rate (2014-2019)
- 3.5.2 Europe Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Cancer Supportive Care Production (2014-2019)
- 3.6.1 China Cancer Supportive Care Production Growth Rate (2014-2019)
- 3.6.2 China Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Cancer Supportive Care Production (2014-2019)
- 3.7.1 Japan Cancer Supportive Care Production Growth Rate (2014-2019)
- 3.7.2 Japan Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Cancer Supportive Care Consumption by Regions
- 4.1 Global Cancer Supportive Care Consumption by Regions
- 4.2 North America Cancer Supportive Care Consumption (2014-2019)
- 4.3 Europe Cancer Supportive Care Consumption (2014-2019)
- 4.4 China Cancer Supportive Care Consumption (2014-2019)
- 4.5 Japan Cancer Supportive Care Consumption (2014-2019)
5 Global Cancer Supportive Care Production, Revenue, Price Trend by Type
- 5.1 Global Cancer Supportive Care Production Market Share by Type (2014-2019)
- 5.2 Global Cancer Supportive Care Revenue Market Share by Type (2014-2019)
- 5.3 Global Cancer Supportive Care Price by Type (2014-2019)
- 5.4 Global Cancer Supportive Care Production Growth by Type (2014-2019)
6 Global Cancer Supportive Care Market Analysis by Applications
- 6.1 Global Cancer Supportive Care Consumption Market Share by Application (2014-2019)
- 6.2 Global Cancer Supportive Care Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Cancer Supportive Care Business
- 7.1 Amgen
- 7.1.1 Amgen Cancer Supportive Care Production Sites and Area Served
- 7.1.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.1.3 Amgen Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Helsinn Healthcare
- 7.2.1 Helsinn Healthcare Cancer Supportive Care Production Sites and Area Served
- 7.2.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.2.3 Helsinn Healthcare Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Johnson &Johnson
- 7.3.1 Johnson &Johnson Cancer Supportive Care Production Sites and Area Served
- 7.3.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.3.3 Johnson &Johnson Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Merck
- 7.4.1 Merck Cancer Supportive Care Production Sites and Area Served
- 7.4.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.4.3 Merck Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 F. Hoffmann-La Roche
- 7.5.1 F. Hoffmann-La Roche Cancer Supportive Care Production Sites and Area Served
- 7.5.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.5.3 F. Hoffmann-La Roche Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 GlaxoSmithKline
- 7.6.1 GlaxoSmithKline Cancer Supportive Care Production Sites and Area Served
- 7.6.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.6.3 GlaxoSmithKline Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Novartis
- 7.7.1 Novartis Cancer Supportive Care Production Sites and Area Served
- 7.7.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.7.3 Novartis Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 TESARO
- 7.8.1 TESARO Cancer Supportive Care Production Sites and Area Served
- 7.8.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.8.3 TESARO Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Teva Pharmaceutical Industries
- 7.9.1 Teva Pharmaceutical Industries Cancer Supportive Care Production Sites and Area Served
- 7.9.2 Cancer Supportive Care Product Introduction, Application and Specification
- 7.9.3 Teva Pharmaceutical Industries Cancer Supportive Care Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
8 Cancer Supportive Care Manufacturing Cost Analysis
- 8.1 Cancer Supportive Care Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Cancer Supportive Care
- 8.4 Cancer Supportive Care Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Cancer Supportive Care Distributors List
- 9.3 Cancer Supportive Care Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Cancer Supportive Care Market Forecast
- 11.1 Global Cancer Supportive Care Production, Revenue Forecast
- 11.1.1 Global Cancer Supportive Care Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Cancer Supportive Care Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Cancer Supportive Care Price and Trend Forecast (2019-2025)
- 11.2 Global Cancer Supportive Care Production Forecast by Regions (2019-2025)
- 11.2.1 North America Cancer Supportive Care Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Cancer Supportive Care Production, Revenue Forecast (2019-2025)
- 11.2.3 China Cancer Supportive Care Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Cancer Supportive Care Production, Revenue Forecast (2019-2025)
- 11.3 Global Cancer Supportive Care Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Cancer Supportive Care Consumption Forecast (2019-2025)
- 11.3.2 Europe Cancer Supportive Care Consumption Forecast (2019-2025)
- 11.3.3 China Cancer Supportive Care Consumption Forecast (2019-2025)
- 11.3.4 Japan Cancer Supportive Care Consumption Forecast (2019-2025)
- 11.4 Global Cancer Supportive Care Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Cancer Supportive Care Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.
The global Cancer Supportive Care market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cancer Supportive Care volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Supportive Care market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
TESARO
Teva Pharmaceutical Industries
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
Segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others